8 Best Treatments for Chronic Tension-Type Headache in 2026

Chronic tension-type headache (CTTH) is defined as headache occurring on 15+ days per month for longer than three months. It is the most prevalent primary headache disorder worldwide, affecting an estimated 122 million US adults. Unlike episodic tension headache, which comes and goes, CTTH is near-constant, with a pressing or tightening quality that can persist for hours, days, or without interruption.

What makes CTTH particularly difficult to manage is the role of central sensitization, a process where the central nervous system amplifies pain signals even in the absence of new tissue damage. A 2026 integrative review in the Journal of Clinical Medicine describes CTTH as involving four interconnected domains: peripheral musculoskeletal dysfunction, central neurophysiological changes, psychosocial stressors, and behavioral and lifestyle factors. Effective treatment typically needs to address more than one of these domains.

Key Takeaways

• Chronic tension-type headache affects 15+ days per month for 3+ months, driven by central sensitization rather than acute tissue injury, and affects roughly 1 in 3 US adults at some point.
• Psychological and behavioral therapies reduce headache days significantly (by approximately 4.5 per month) in adults with TTH, with more than double the treatment response rate compared to controls.
• Amitriptyline is the highest-ranked preventive medication for reducing monthly headache days, though evidence certainty is low and side effects are common.
• Physical therapy, acupuncture, and biofeedback each have recent meta-analytic support for reducing headache frequency and intensity in adults with CTTH.
• A multidisciplinary approach combining behavioral, pharmacological, physical, and lifestyle strategies addresses the multiple domains that sustain chronic tension-type headache.

1. Brain-Based Behavioral Therapy

Behavioral and psychological therapies address CTTH at the level of the nervous system, targeting the central sensitization and psychosocial mechanisms that keep headache locked in a chronic cycle. For a condition where medications alone often provide incomplete relief, these approaches offer an evidence-based path that works with the brain's own pain-processing system.

How It Works

In CTTH, prolonged nociceptive input from pericranial muscles leads to spinal and trigeminal sensitization, meaning the brain's pain alarm becomes increasingly sensitive over time. Psychological stress, anxiety, and passive coping strategies amplify this process. A 2026 multidimensional framework for CTTH identifies psychological and behavioral factors as one of four core drivers, not just a byproduct, of the condition.

Brain-based behavioral therapies work by retraining how the nervous system processes and responds to pain signals. Cognitive behavioral therapy (CBT) helps patients identify and restructure the thought patterns, avoidance behaviors, and stress responses that reinforce chronic headache. Acceptance and commitment therapy (ACT) builds psychological flexibility, helping patients reengage with daily life despite ongoing symptoms. Relaxation training, including progressive muscle relaxation and diaphragmatic breathing, directly reduces pericranial muscle tension and sympathetic nervous system activation.

Evidence for Tension-Type Headache

A 2025 meta-analysis of 19 randomized controlled trials (1,069 participants) in The Journal of Headache and Pain found that psychological interventions reduce headache days substantially (MD = -4.53 per month) compared to controls, with moderate-quality evidence. The treatment response rate was more than double that of controls (RR = 2.43), and headache intensity also decreased significantly (MD = -1.88 on standardized pain scales).

Across decades of research, behavioral treatments have produced 37% to 50% reductions in TTH frequency, comparing favorably with the 33% reduction typically seen with amitriptyline prophylaxis, and without the side effects associated with daily medication.

Accessing Behavioral Therapy

Programs like Lin Health deliver brain-based behavioral therapies, including CBT, ACT, somatic tracking, and relaxation-based techniques, through trained recovery coaches. Treatment includes weekly live sessions, between-session chat support, and a structured app-based curriculum. The program is covered by most major insurance carriers in Colorado, Texas, Florida, California, and New York, with short wait times and often a same-day callback after sign-up. For people with CTTH who have not found adequate relief from medication alone, adding behavioral therapy may address the central sensitization component that medications do not reach.

2. Preventive Medications

Daily preventive medication is a first-line treatment for CTTH in most clinical practice guidelines. The goal is to reduce headache frequency and severity over weeks to months, even when complete headache freedom is uncommon.

How They Work

Preventive medications for CTTH primarily target neurotransmitter systems involved in pain modulation. Tricyclic antidepressants (amitriptyline, nortriptyline) modulate serotonin and norepinephrine pathways and reduce central sensitization. SNRIs (venlafaxine) act on overlapping pain and mood pathways. Muscle relaxants (tizanidine) reduce pericranial muscle tone.

Evidence in CTTH

A 2026 network meta-analysis of 35 randomized trials (2,795 participants) published in Annals of Medicine found that amitriptyline 100 mg was the highest-ranked preventive treatment for reducing monthly headache days at 4, 8, and 12 weeks. The effect size was substantial: approximately 6.6 fewer headache days per month at 4 weeks and 6.1 fewer at 8 weeks compared to placebo.

Botulinum toxin A (100 units) also showed benefit, with approximately 3.8 fewer headache days at 8 weeks, though with very low certainty evidence.

What to Expect

Preventive medications typically require 4 to 8 weeks at therapeutic doses before meaningful benefit appears. Side effects are a significant consideration: amitriptyline commonly causes drowsiness, dry mouth, and weight gain, with substantially higher adverse event rates than placebo (OR 9.53 at 100 mg). The certainty of evidence across all pharmacological interventions for CTTH remains low to very low, which is why clinical guidelines increasingly recommend combining medication with non-pharmacological approaches rather than relying on drugs alone.

3. Physical Therapy and Exercise

Physical therapy and structured exercise programs target the musculoskeletal component of CTTH, addressing the pericranial muscle dysfunction and cervical impairments that feed into central sensitization.

How They Work

CTTH involves measurable changes in the neck and shoulder musculature, including reduced deep cervical muscle thickness, myofascial trigger points, and restricted cervical mobility. Physical therapy interventions address these peripheral drivers through manual techniques, targeted strengthening, and motor retraining. Structured aerobic and resistance exercise also activates descending pain inhibitory pathways, directly modulating central pain processing.

Evidence in CTTH

A 2025 meta-analysis of 9 randomized trials found that neck and shoulder strengthening exercises and muscle relaxation approaches significantly reduced headache intensity (SMD = -1.17, p < 0.01), headache duration (SMD = -0.71, p = 0.02), and headache frequency (SMD = -1.36, p = 0.02) in adults with CTTH.

A separate 2025 systematic review of 10 trials (848 participants) found that significant frequency reductions in 90% of studies in the exercise group compared to controls. Combined interventions integrating exercise with manual therapy or pain education yielded stronger results than exercise alone.

What to Expect

Physical therapy programs for CTTH typically last 4 to 12 weeks, with regular sessions (2 to 3 per week) providing optimal results. Cervical strengthening, postural correction, and progressive aerobic training are the most commonly studied protocols. Unlike medication, exercise has a favorable side-effect profile and provides additional benefits for mood, sleep, and cardiovascular health. Physical therapy works well as part of a broader treatment plan that includes behavioral strategies and, when needed, medication.

4. Acupuncture

Acupuncture is a well-studied complementary treatment for tension-type headache, with meta-analytic evidence supporting its use for headache frequency reduction in adults with CTTH.

How It Works

Acupuncture involves inserting fine needles at specific body points. The proposed mechanisms include activation of endogenous opioid systems, modulation of serotonergic and noradrenergic pathways, and reduction of central sensitization through descending pain inhibition. In CTTH, these effects may help reverse the amplified pain processing that sustains the headache cycle.

Evidence in CTTH

A 2025 meta-analysis of 6 randomized trials (927 patients) found that acupuncture reduced headache frequency compared to sham acupuncture at 6 weeks (SMD = -0.23, p = 0.03). Patients receiving acupuncture had nearly double the odds of headache relief (OR = 1.85, p < 0.001). In subgroup analysis, treatment courses longer than one month or exceeding 10 sessions produced larger effect sizes (SMD = -0.32, p = 0.006).

The Cochrane Collaboration's review of acupuncture for TTH concluded that at least six sessions is a valuable treatment option for people with frequent episodic or chronic TTH.

What to Expect

A typical treatment course involves 10 to 12 sessions over 6 to 8 weeks. Side effects are minimal, most commonly mild soreness or bruising at needle sites. Acupuncture may be particularly appealing for patients who prefer non-pharmacological approaches or who have not tolerated preventive medications. It can be combined with behavioral therapy and medication as part of a multimodal plan.

5. Biofeedback

Biofeedback, particularly EMG (electromyographic) biofeedback, teaches patients to gain voluntary control over physiological responses that contribute to tension-type headache, including pericranial muscle tension and sympathetic arousal.

How It Works

In EMG biofeedback, sensors placed on the forehead or neck muscles provide real-time visual or auditory feedback on muscle tension levels. Patients learn to recognize and reduce elevated muscle activity through guided practice. Over time, this conscious control becomes more automatic, reducing the peripheral muscle tension that feeds into central sensitization. Temperature biofeedback and heart rate variability biofeedback are also used, typically in combination with relaxation training.

Evidence in CTTH

A 2023 systematic review and meta-analysis of 29 randomized trials (1,342 participants) evaluating EMG biofeedback for headache found a reduction in headache intensity (effect size 0.21) across the treatment pool. EMG biofeedback combined with relaxation training produced the strongest results, and biofeedback performed comparably to pharmacotherapy in head-to-head comparisons.

The 2025 psychological treatment meta-analysis in The Journal of Headache and Pain included biofeedback as one of the interventions reducing TTH headache days by 4.53 per month in TTH populations.

Historical meta-analyses specific to TTH have documented 37% to 50% reductions in headache frequency with biofeedback, with larger effects in patients with longer headache histories and in younger populations.

What to Expect

Biofeedback typically involves 8 to 12 sessions with a trained therapist, with home practice between sessions. The technique has virtually no side effects and can be combined with CBT, relaxation training, or medication. It may be particularly useful for patients who want a structured, measurable approach to self-regulation. Some newer biofeedback programs are delivered via digital platforms, expanding access beyond traditional clinical settings.

6. OnabotulinumtoxinA (Botox) Injections

OnabotulinumtoxinA, widely known as Botox, is FDA-approved for chronic migraine and used off-label for CTTH in some headache and pain clinics.

How It Works

OnabotulinumtoxinA is injected into specific pericranial and cervical muscle groups. Beyond reducing muscle contraction, it blocks the release of pain-signaling molecules (CGRP, substance P, glutamate) at peripheral nerve endings, which may reduce the peripheral nociceptive input that drives central sensitization in CTTH.

Evidence in CTTH

A 2023 systematic review and meta-analysis published in Cephalalgia found that botulinum toxin A improved intensity, frequency, and duration in adults with CTTH. A 2026 network meta-analysis ranked botulinum toxin A 100 units as effective for reducing headache days, with approximately 3.8 fewer days per month at 8 weeks compared to placebo, though evidence certainty was very low.

At higher doses (500 units), the adverse event rate increased substantially (OR 19.04), making lower doses the preferred clinical approach.

What to Expect

Treatment cycles occur every 12 weeks, with two to three cycles often needed before full benefit is apparent. Common side effects include injection-site pain, neck stiffness, and temporary muscle weakness. Insurance coverage typically requires documented failure of oral preventives and, in many plans, a chronic migraine diagnosis, which may create an access barrier for patients with CTTH specifically. Botox may be most appropriate for CTTH patients who have not responded to multiple oral medications and behavioral approaches.

7. Neuromodulation Devices

Non-invasive neuromodulation devices offer medication-free treatment options for headache. Their evidence base for TTH is still developing, though related data from migraine and chronic daily headache trials is encouraging.

Available Devices

• Cefaly (e-TNS): External trigeminal nerve stimulator worn on the forehead. FDA cleared for migraine prevention and acute treatment. An open-label study in frequent TTH found that 66% reported pain relief during attacks.
• TENS (transcutaneous electrical nerve stimulation): Applied to the occipital or cervical region. HeadaTerm 2 received FDA clearance for 20-minute preventive headache treatments.

Evidence

For TTH specifically, published clinical data from randomized trials remain limited. Neuromodulation is positioned as a favorable due to tolerability, particularly for patients who cannot tolerate or prefer to avoid daily medication. The 2025 International Headache Society evidence-based guidelines support non-invasive neuromodulation for migraine, and extrapolation to CTTH with shared central sensitization mechanisms is an active area of research.

What to Expect

These devices are used at home and are generally well tolerated. Side effects are minimal, most commonly mild tingling or skin irritation at the stimulation site. They can be combined with medication, behavioral therapy, and physical therapy. Cost and insurance coverage vary by device and payer, with some devices available by prescription and others over the counter.

8. Lifestyle Modifications and Stress Management

Lifestyle factors form the foundation of any CTTH management plan. While rarely sufficient as standalone treatments, they support and amplify the effects of every other therapy on this list.

Sleep

Sleep disturbance is strikingly common in tension-type headache. A 2026 meta-analysis of 27 studies found that 67% have poor sleep quality among people with TTH, measured by the Pittsburgh Sleep Quality Index. Poor sleep increases pericranial muscle tension, reduces pain thresholds, and worsens central sensitization. Prioritizing consistent sleep and wake times, limiting screen exposure before bed, and treating any underlying sleep disorder (insomnia, sleep apnea) are foundational steps. Practical sleep strategies can meaningfully reduce headache burden when applied consistently.

Stress Management

Psychological stress is one of the most consistently identified triggers for TTH. In population-based studies, anxiety prevalence among people with frequent TTH reaches 21.4% in those with more than 15 attacks per month, roughly four times the rate in non-headache populations. Active coping strategies like structured relaxation, pacing, and pain journaling are associated with improved adaptation, while passive strategies (avoidance, medication overreliance) correlate with increased disability.

Exercise

Regular aerobic exercise is recommended for adults with CTTH. A 2025 systematic review confirmed that structured exercise programs of 4 weeks or longer significantly reduced headache frequency across 9 of 10 studies. Exercise improves central pain modulation by activating descending inhibitory pain pathways. Walking, cycling, swimming, and yoga are all appropriate starting points, with gradual progression to avoid triggering headache during initial sessions.

Ergonomics and Posture

For people whose headaches are linked to sustained postures (desk work, screen time), ergonomic modifications can reduce the peripheral muscle strain that feeds into the headache cycle. Regular movement breaks, monitor positioning at eye level, and cervical support during prolonged sitting are practical, low-cost interventions.

How Lin Health Helps with Chronic Tension-Type Headache

Chronic tension-type headache involves measurable changes in how the brain and nervous system process pain. The central sensitization documented in CTTH means the brain's pain alarm has become amplified over time, responding to stimuli that would not normally produce pain. This is the same neuroplastic mechanism that Lin Health's approach is designed to address.

Lin Health's program is based on research into cognitive behavioral therapy, acceptance and commitment therapy, pain reprocessing therapy, and relaxation-based techniques. Trained recovery coaches guide patients through weekly live sessions focused on retraining the nervous system's pain response, building stress resilience, addressing the thought-emotion-pain cycle, and developing active coping strategies. Between sessions, a structured app provides guided practices, educational content, and chat access to coaches.

This model fills a critical gap for people with CTTH: access to specialized behavioral and mind-body therapies without the long wait times and high out-of-pocket costs that typically come with pain psychologists or multidisciplinary headache programs. A 2025 meta-analysis found that these types of psychological interventions reduce headache days by over 4 days per month in people with tension-type headache, with treatment response rates more than double those of controls.

Lin Health partners with headache-focused neurology clinics including the NY Headache Center and Summit Headache Institute, and is covered by most major insurance carriers in Colorado, Texas, Florida, California, and New York.

If you are living with chronic tension-type headache and medications alone have not provided lasting improvement, behavioral approaches that target the brain and nervous system may be worth exploring. Lin Health's program is covered by most insurance plans, with short wait times and often a same-day callback after sign-up. Check your eligibility.

FAQ

What is chronic tension-type headache?

Chronic tension-type headache is defined as headache occurring on 15 or more days per month for longer than three months. It typically presents as a bilateral, pressing or tightening sensation of mild-to-moderate intensity that is not aggravated by routine physical activity. It is classified under ICHD-3 code 2.3.

How is chronic tension-type headache different from chronic migraine?

CTTH produces a pressing, band-like pain without the throbbing quality, nausea, or significant light and sound sensitivity that define migraine. Chronic migraine involves 15+ headache days per month with at least 8 meeting migraine criteria. Some patients have features of both conditions and may benefit from treatments that address shared mechanisms like central sensitization.

Can behavioral therapy really help with headaches?

A 2025 meta-analysis of 19 randomized trials found that psychological interventions reduce headache days by approximately 4.5 per month in adults with TTH. These approaches target the central nervous system mechanisms that sustain chronic headache, working alongside (not in place of) medical treatment.

What medication works for chronic tension-type headache prevention?

Amitriptyline is the highest-ranked preventive medication for CTTH based on a 2026 network meta-analysis, reducing headache days by approximately 6 per month compared to placebo. However, evidence certainty is low, and side effects including drowsiness and dry mouth are common. Most patients benefit from combining medication with non-pharmacological approaches.

Does acupuncture work for tension-type headache?

A 2025 meta-analysis found that acupuncture reduced headache frequency compared to sham acupuncture, with nearly double the odds of headache relief. The Cochrane Collaboration concludes that a course of at least six sessions is a valuable option. Acupuncture may work through modulation of descending pain inhibition and central sensitization pathways.

How much does sleep affect tension-type headache?

A 2026 meta-analysis found that 67% of people with tension-type headache have poor sleep quality. Poor sleep reduces pain thresholds and worsens central sensitization. Prioritizing consistent sleep habits is a foundational step in any CTTH management plan.

Is Botox approved for tension-type headache?

Botox is FDA-approved for chronic migraine, not specifically for CTTH. It is used off-label in some headache centers. A 2023 meta-analysis found it improved headache intensity, frequency, and duration in adults with CTTH, but evidence certainty remains low. Insurance coverage typically requires a chronic migraine diagnosis.

Should I combine treatments for chronic tension-type headache?

CTTH involves peripheral musculoskeletal, central neurological, psychological, and lifestyle factors. Addressing multiple domains typically provides more meaningful improvement than any single treatment. Combining behavioral therapy, physical activity, stress management, and medication when needed is supported by current evidence.

This article is for informational purposes and is not medical advice. Consult a qualified healthcare provider before starting, changing, or stopping any treatment for headache or chronic pain.